I-Mab Biopharma HongKong Limited
1 clinical trials · Sponsor
◉ Watch I-Mab Biopharma HongKong Limited
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis (NCT03235752) | I-Mab Biopharma HongKong Limited | 2018-02-06 |
Track I-Mab Biopharma HongKong Limited automatically
Every clearance here is in the API, with alerts when new ones post.